DNA damage response and growth factor signaling pathways in gliomagenesis and therapeutic resistance
about
KRAS mutation is a predictor of oxaliplatin sensitivity in colon cancer cellsPotentiating the efficacy of molecular targeted therapy for hepatocellular carcinoma by inhibiting the insulin-like growth factor pathwaySemapimod sensitizes glioblastoma tumors to ionizing radiation by targeting microgliaPreclinical pharmacological evaluation of a novel multiple kinase inhibitor, ON123300, in brain tumor modelsMicroRNA-17-5p promotes chemotherapeutic drug resistance and tumour metastasis of colorectal cancer by repressing PTEN expression.Evolution of malignant glioma treatment: from chemotherapy to vaccines to viruses.Systemic anticancer neural stem cells in combination with a cardiac glycoside for glioblastoma therapyIn search of druggable targets for GBM amino acid metabolism.Small ubiquitin-like modifier 1-3 conjugation [corrected] is activated in human astrocytic brain tumors and is required for glioblastoma cell survival.Oxaliplatin-based Chemotherapy Might Provide Longer Progression-Free Survival in KRAS Mutant Metastatic Colorectal Cancer.Inhibition of DYRK1A destabilizes EGFR and reduces EGFR-dependent glioblastoma growth.ATM kinase inhibition preferentially sensitizes p53-mutant glioma to ionizing radiationCytotoxic activity of the MK2 inhibitor CMPD1 in glioblastoma cells is independent of MK2.Glioblastoma multiforme: Effect of hypoxia and hypoxia inducible factors on therapeutic approachesMET inhibition overcomes radiation resistance of glioblastoma stem-like cells.MET signaling promotes DNA repair and radiation resistance in glioblastoma stem-like cells.Clinical aggressiveness of malignant gliomas is linked to augmented metabolism of amino acids.Enhancing radiation therapy for patients with glioblastoma.Newly developed strategies for improving sensitivity to radiation by targeting signal pathways in cancer therapy.EGFR-dependent mechanisms in glioblastoma: towards a better therapeutic strategy.Flavopiridol: An Old Drug With New Perspectives? Implication for Development of New Drugs.MiR-338-5p sensitizes glioblastoma cells to radiation through regulation of genes involved in DNA damage response.Preclinical evaluation of dipotassium bisperoxo (picolinato) oxovanadate V for the treatment of pediatric low-grade gliomas.The role of radiation in treating glioblastoma: here to stay.Chemotherapeutic Drugs: DNA Damage and Repair in Glioblastoma.Sorafenib and HDAC inhibitors synergize to kill CNS tumor cells.Dynamic inhibition of ATM kinase provides a strategy for glioblastoma multiforme radiosensitization and growth control.DNA damage of glioblastoma multiform cells induced by Beta radiation of iodine-131 in the presence or absence of topotecan: a picogreen and colonogenic assayUBE2S, a novel substrate of Akt1, associates with Ku70 and regulates DNA repair and glioblastoma multiforme resistance to chemotherapy.53BP1 is a haploinsufficient tumor suppressor and protects cells from radiation response in glioma.To go or not to go?CMPD1 inhibited human gastric cancer cell proliferation by inducing apoptosis and G2/M cell cycle arrest.Identification and preclinical evaluation of the small molecule, NSC745887, for treating glioblastomas via suppressing DcR3-associated signaling pathways.Next-Generation Modeling of Human CancersGlioblastoma Chemoresistance: The Double Play by Microenvironment and Blood-Brain Barrier
P2860
Q28485355-1FCF9237-820F-458D-82C9-556F2F2C0CDEQ28534009-901FB33F-493B-4708-AA32-C180ADB2DD6EQ28538650-D394028E-67B3-422E-BE53-2B1C5BBC3623Q33578960-3A9ABE09-8DC2-4A9C-8513-1F03A84D4733Q33917538-D42FB2E4-AF0C-4ABE-82B5-748D16755B67Q33923950-2C2CBA79-2D1B-4FFC-B431-2B7F54FAD216Q35679830-6177AD42-2065-4215-9803-EEA36D094180Q36293108-FFBD4C06-1335-4AB6-8BDA-61BA952E4BC4Q36717273-D7B739EC-5C09-462F-BD37-32AF952B04B7Q36865085-D26031C7-EE43-4690-A29E-623629239325Q36891085-BF7DBEFC-CDF4-4065-BBF4-732F361F52B6Q36941509-8FF5D30F-CB32-45E2-A62D-6641C89B491DQ37164205-D7EA2AD4-9FA5-4621-9699-AFA5C25BE52CQ37287987-95D53B0A-BBC6-4D41-86AF-F0DBA62E334BQ37458626-BAE23BD5-4701-4CDB-9A2D-99979BFB03D5Q37666955-7EE67E63-698B-4325-93F3-66653541EEFDQ37730054-AEA7A2A3-1339-4165-A615-1252816C5F65Q38101608-84E19CEA-A0D7-489F-A5F0-3C59B7621AB5Q38127721-79E486A4-14B6-43FC-834A-561D8033378EQ38199643-B8612FB1-2F05-4D9B-BE67-6FB3A58E4146Q38735367-DB043E14-C92A-42F2-8874-F0EBB22F48F0Q38809897-69410361-B21D-4899-9809-D6A1CE7A4235Q39117557-39E5DF4B-3BBA-493B-B5AF-4504C2F5B9F7Q39167423-05A68F7C-5195-4D8B-9973-E594FC90204BQ39354541-2D687994-D546-4996-AE1A-FA826FBB010CQ39381898-BD166E57-0D33-4C8C-8395-84100E834104Q39389281-89405EDA-9C04-4D2B-AD5D-F6B6167DC4B4Q39527014-E57D6436-0A82-4F12-BA44-DC69B960807AQ40595329-19E143E5-E33A-45C1-A0C4-AD6C321A7255Q42052679-4CEC3F73-0909-4CB1-A3EA-C8F942E08F31Q42132128-EE20F9E2-AFCD-412E-8A4D-145B0413559DQ52585066-7DB309D3-2E2D-47C7-A08B-387933D8FFCAQ52649617-89196187-59B8-4B12-9A0E-9D66301BA21DQ58576103-516598D4-1DB1-4899-9FE9-E97D9B5FEC90Q59134092-EC0E3B23-7276-4A2E-9FEE-8EEEE0004196
P2860
DNA damage response and growth factor signaling pathways in gliomagenesis and therapeutic resistance
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
DNA damage response and growth ...... sis and therapeutic resistance
@ast
DNA damage response and growth ...... sis and therapeutic resistance
@en
DNA damage response and growth ...... sis and therapeutic resistance
@nl
type
label
DNA damage response and growth ...... sis and therapeutic resistance
@ast
DNA damage response and growth ...... sis and therapeutic resistance
@en
DNA damage response and growth ...... sis and therapeutic resistance
@nl
prefLabel
DNA damage response and growth ...... sis and therapeutic resistance
@ast
DNA damage response and growth ...... sis and therapeutic resistance
@en
DNA damage response and growth ...... sis and therapeutic resistance
@nl
P3181
P1433
P1476
DNA damage response and growth ...... sis and therapeutic resistance
@en
P2093
Eric C Holland
P304
P3181
P356
10.1158/0008-5472.CAN-11-1245
P407
P577
2011-09-13T00:00:00Z